Antibody composition exhibiting increased cellular cytotoxicity due to glycosylation
US7741442B2 · kind B2 · utility
20Cited by
44References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 6, 2005 |
| Grant date | Jun 22, 2010 |
| Priority date | — |
| Expiry date | May 30, 2026 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates to a cell for the production of an antibody molecule such as an antibody useful for various diseases having high antibody-dependent cell-mediated cytotoxic activity, a fragment of the antibody and a fusion protein having the Fc region of the antibody or the like, a method for producing an antibody composition using the cell, the antibody composition and use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.